Stock comparison
RESMED INC is 6.1x more valuable than HAEMONETICS CORP by market capitalization ($33.09 B vs $5.46 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
RMD is larger
RESMED INC is 6.1x more valuable than HAEMONETICS CORP by market capitalization ($33.09 B vs $5.46 B).
Market value leader
RMD
RESMED INC is 6.1x more valuable than HAEMONETICS CORP by market capitalization ($33.09 B vs $5.46 B).
Revenue leader
RMD
HAE: $1.33B vs RMD: $5.65B.
Profit leader
RMD
HAE: $97.31M vs RMD: $1.52B.
Margin leader
RMD
HAE: 7.3% vs RMD: 26.9% net margin.
| Metric | HAE | RMD |
|---|---|---|
| Market cap | $5.46 B | $33.09 B |
| US-listed rank | #1321 | #432 |
| Revenue (latest FY) | $1.33B | $5.65B |
| Net income (latest FY) | $97.31M | $1.52B |
| Net margin | 7.3% | 26.9% |
| P/E (trailing FY) | 56.1x | 21.7x |
| SEC filings | 1,875 | 2,518 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
RESMED INC is 6.1x more valuable than HAEMONETICS CORP by market capitalization ($33.09 B vs $5.46 B).
In their latest fiscal years, HAEMONETICS CORP reported $1.33B in revenue while RESMED INC reported $5.65B.
Full pages: HAEMONETICS CORP and RESMED INC, or browse the full rankings.